[Recombinant human erythropoietin--blood transfusion alternative].
Morshakova
E F
EF
Ryazan Branch of Research Institute of Pediatric Haematology.
D000740:Anemia / Q000097:blood / Q000209:etiology / Q000628:therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007501:Iron / Q000097:blood; D007676:Kidney Failure, Chronic / Q000150:complications; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D011878:Radiotherapy / Q000009:adverse effects; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa; D007501:Iron
Rekombinantnyĭ chelovecheskiĭ érytropoetin--al'ternativa gemotransfuziiam.